A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

2,516

Participants

Timeline

Start Date

September 2, 2022

Primary Completion Date

August 22, 2024

Study Completion Date

August 22, 2024

Conditions
Asthma
Interventions
DRUG

BDA MDI

Participants will receive Budesonide and Albuterol Sulfate MDI 80/90 μg per Actuation 1 to 6 doses (2 inhalations/dose) per day as needed via Oral inhalation route.

DRUG

AS MDI

Participants will receive Albuterol Sulfate MDI 90 μg per Actuation 1 to 6 doses (2 inhalations/dose) per day as needed via Oral inhalation route.

Trial Locations (61)

10001

Modern Migraine MD/CTNX, New York

13760

Meridian Clinical Research, Endwell

19040

Hatboro Medical Associates, Hatboro

21162

Chesapeake Clinical Research, White Marsh

21225

Baltimore Early Phase Clinical Unit (EPCU), Baltimore

21401

Javara Inc., Annapolis

23703

Meridian Clinical Research, Portsmouth

27012

Javara Inc/Wake Forest Health Network, LLC, Clemmons

27607

North Carolina Clinical Research, Raleigh

28112

Monroe Biomedical Research, Monroe

28277

Javara Inc., Charlotte

28401

Wilmington Health (Innovo Research), Wilmington

29615

Velocity Clinical Research, Greenville, Greenville

29621

Velocity Clinical Research - Anderson, Anderson

30047

Lifeline Primary Care, Lilburn

31406

Javara Inc./Privia Medical Group Georgia, LLC, Savannah

31904

Centricity Research, Columbus

31905

Centricity Research, Columbus

31906

Centricity Research, Columbus

31907

Centricity Research, Columbus

32308

Allergy and Asthma Diagnostic Treatment Center, Tallahassee

33435

Helix Biomedics, Boynton Beach

36608

Pulmonary Associates of Mobile PC, Mobile

43207

Buckeye Health and Research, Columbus

46383

Velocity Clinical Research - Valparaiso, Valparaiso

56001

Mankato Clinic, Mankato

64118

Spectrum Clinical Research, Kansas City

68144

Midwest Regional Health Services, LLC/CCT Research, Omaha

68510

Meridian Clinical Research, LLC, Lincoln

70508

Velocity Clinical Research, Lafayette

75020

CardioVoyage LLC, Denison

76133

Texas Health Care, PLLC d/b/a Privia Medical Group- North Texas, Fort Worth

77433

Privia Medical Group Gulf Coast, Cypress

77479

Mt. Olympus Medical Research, Sugar Land

77546

Allure Health at Mt Olympus Medical Research, Friendswood

77584

LinQ Research, LLC, Pearland

78759

Velocity Clinical Research, Austin, Cedar Park

80209

Velocity Clinical Research, Denver, Denver

80907

Asthma and Allergy Associates, Colorado Springs

83642

Velocity Clinical Research - Boise, Meridian

84088

Velocity Clinical Research -Salt Lake City, West Jordan

84405

South Ogden Family Medicine clinic, Ogden

85253

One of a Kind Clinical Research Center, Paradise Valley

85283

Fiel Family and Sports Medicine/CCT Research, Tempe

90230

Science 37, Culver City

92123

Allergy & Asthma Medical Group and Research (AAMGRC) - Allergy, Asthma and Immunology, San Diego

93301

Kern Research Inc., Bakersfield

93534

Antelope Valley Clinical Trials, Lancaster

94598

Clinical Research of California, Walnut Creek

97202

Northwest Research Center, Portland

97504

Velocity Clinical Resarch - Medford, Medford

02723

Genesis Clinical Research and Consulting, LLC, Fall River

02747

Infinity Medical Research, North Dartmouth

02818

Velocity Clinical Research - Providence, East Greenwich

02886

AAPRI Clinical Research Institute, Warwick

02895

CVS Health, Woonsocket

02896

CVS Health, Woonsocket

02897

CVS Health, Woonsocket

02898

CVS Health, Woonsocket

02899

CVS Health, Woonsocket

02900

CVS Health, Woonsocket

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Parexel

INDUSTRY

lead

Bond Avillion 2 Development LP

INDUSTRY

NCT05505734 - A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma | Biotech Hunter | Biotech Hunter